Skip to main content

Table 3 Results of literature review

From: Pulmonary sclerosing pneumocytoma: clinical features and prognosis

Author Years Patients Female Age Size, cm Lobe locationa Extent of resection Survival status
      RUL RML RLL LUL LLL Lobectomy Sub-lobectomy Lost to follow-up Dead Alive
K.W. Chan [20] 1982 14 14 50 (16.21) 2.33 (0.64) 0 2 5 4 1 9 1 6 1 7
A.S Fassina [21] 1986 6 3 59 (9.72) 1.83 (0.59)       4 2 1   5
N.P Ohori [22] 1991 14 14 45 (14.65)          3 3 8
A.C. Chan [23] 2000 1 6 15 52 (14.13) 2.39 (1.65) 1 5 4 0 6      
J.E. Nam [24] 2002 2 2 50 (16.26) 2.25 (1.06) 0 0 0 0 2      
M.C. Aubry [25] 2002 16 16 50 (12.65) 2.96 (2.35)       1 10 1 1 14
Y.C. Cheung [26] 2003 6 5 35 (14.58)        6 2    
K. Yamazaki [27] 2004 7 7 54 (14.30) 4.50 (3.22)           
S.D. Sak [28] 2007 26 16 53 (9.76) 2.08 (1.31) 5 2 3 2 14      
G. Sartori [29] 2007 11 10 47 (11.00) 3.09 (0.80) 1 2 0 4 4 5 6    11
S. Islam [30] 2009 6 3 56 (9.75) 1.92 (0.59)       1 1    
K.H. Lin [31] 2011 6 5 50 (11.29) 2.87 (1.55) 0 1 1 1 3      
Q.B. Wang [32] 2011 16 14 53 (11.66)   1 9 4 2 1      
Lee, E [33]. 2013 26 23 44 (11.47) 2.47 (1.26) 2 6 6 2 8      
C.Y. Wu [34] 2016 14 14 53 (15.12) 2.26 (1.41) 2 2 2 3 5      
A. Lovrenski [35] 2019 6 5 51 (9.00) 1.75 (0.50) 0 0 1 2 3      6
J. Xu [36] 2019 22 12 54 (12.76) 2.59 (1.38)           
Q. Gao [37] 2020 32 23 41 (18.57) 4.77 (3.11) 4 1 9 6 12      
Overall   246 201 49 (14.51) 2.75 (1.95) 16 30 35 26 59 26 22 11 5 51
Median (range)     51(10-78) 2.20 (0.50-1.20)           
  1. The data was presented as mean (SD) or median (range)
  2. a LUL left upper lobe, LLL left lower lobe, RLL right lower lobe, RML, right middle lobe, RLL right lower lobe